News 'Sugar tax' already working, say health campaigners Many drinks manufacturers have changed recipes to avoid tax
News BI strikes billion-dollar cancer immunotherapy deal with OSE Could BI be looking to develop combination therapy?
Oncology Celgene's COO quits after troubles with new drugs Celgene’s chief operating officer and inflammatory diseases guru Scott Smith has quit the company, in the aftermath of the FDA’s rejection of a key multiple sclerosis pill, and a late-stage
News Pfizer's lung cancer drug dacomitinib gets fast US review Drug beat AZ's Iressa in head-to-head trial, concerns over side-effects
News Ex-Kite chiefs' biotech to research 'off-the-shelf' CAR-Ts w... Belldegrun and Chang's Allogene to take over from Pfizer in R&D deal
News UK's Levicept builds case for osteoarthritis therapy at ACR New data on Levicept's LEVI-04 in patients with osteoarthritis support its potential to become the first new systemic treatment in over two decades.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
